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Abstract
Objectives We hypothesized that three-dimensional pseudo-
continuous arterial spin labelling (pCASL) may have similar
efficacy in astrocytic tumour grading as dynamic susceptibility
contrast-enhanced perfusion-weighted imaging (DSC-PWI),
and the grading accuracy may be further improved when com-
bined with apparent diffusion coefficient (ADC) values.
Methods Forty-three patients with astrocytic tumours were
studied using diffusion weighted imaging (DWI), pCASL,
and DSC-PWI. Histograms of ADC and normalized tumour
cerebral blood flow values (nCBF on pCASL and nrCBF on
DSC-PWI) were measured and analyzed.
Results The mean 10 % ADC value was the DWI parameter
that provided the best differentiation between low-grade as-
trocytoma (LGA) and high-grade astrocytoma (HGA). The
nCBF and nrCBF (1.810±0.979 and 2.070±1.048) in LGA
were significantly lower than those (4.505±2.270 and 5.922±
2.630) in HGA. For differentiation between LGA and HGA,
the cutoff values of 0.764×10-3 mm2/s for mean 10 % ADC,
2.374 for nCBF, and 3.464 for nrCBF provided the optimal
accuracy (74.4 %, 86.1 %, and 88.6 %, respectively). Com-
bining the ADC values with nCBF or nrCBF could further
improve the grading accuracy to 97.7 % or 95.3 %,
respectively.
Conclusions pCASL is an alternative to DSC-PWI for astro-
cytic tumour grading. The combination of DWI and contrast-
free pCASL offers a valuable choice in patients with risk
factors.
Key Points
• pCASL shows positive correlation with DSC-PWI in astro-
cytic tumour grading.
• ADC values based on ADC histograms can be an objective
method.
• Combination of DWI and pCASL or DSC-PWI can improve
grading accuracy.
Keywords Three-dimensional pseudocontinuous arterial spin
labelling . Dynamic susceptibility contrast-enhanced
perfusion-weighted imaging . Diffusion-weighted imaging .
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Introduction
Astrocytic tumours of the central nervous system are classi-
fied by the World Health Organization into four grades ac-
cording to pathological appearance. The tumour grading is
of great importance in predicting the biological behaviour of
the tumours and offers important guidance for accurate tu-
mour biopsy and therapeutic decisions such as surgery, adju-
vant radiation, and chemotherapy protocols [1], especially in
non-resectable tumours. For these reasons, numerous efforts
have been made to assess the astrocytic tumour grading using
noninvasive imaging methods. Currently, conventional mag-
netic resonance imaging (MRI) techniques using T2-weighted
image (T2WI), fluid attenuated inversion recovery (FLAIR),
and pre-contrast and post-contrast T1-weighted image (T1WI)
scans are routinely used for the examination of brain tumours,
but accurate assessment of tumour grading cannot be achieved
in some cases.
Some of the advanced MRI techniques, such as diffusion
weighted imaging (DWI) and dynamic susceptibility contrast-
enhanced perfusion-weighted imaging (DSC-PWI), have
shown promise in brain tumour grading [1–4]. By providing
information derived from the microscopic motion of water
molecules, the minimum apparent diffusion coefficient
(ADC) values obtained by manually drawn regions of interest
(ROIs) on an ADC map can enable the assessment of tumour
cellularity and proliferation [4]. Accordingly, minimum ADC
values can be used for brain tumour grading. DSC-PWI
has been widely used as a valuable method for brain
tumour grading, since it can be used to assess the tu-
mour neovascularity. A previous DSC-PWI study sug-
gested that the maximum relative cerebral blood volume
(rCBV) and relative cerebral blood flow (rCBF) corre-
lated well with the brain tumour grades [5]. But the
application of DSC-PWI involved the use of contrast
media injection, which could cause complications, in-
cluding nephrogenic systemic fibrosis in patients with
chronic kidney disease. Arterial spin labelling (ASL)
technique, however, is an entirely noninvasive alterna-
tive to DSC-PWI, and it could be categorized as either
a continuous or pulsed ASL technique [6]. A newly
developed ASL sequence, three-dimensional pseudocon-
tinuous arterial spin labelling (pCASL), has potentially
combined the advantages of pulsed ASL and continuous
ASL, and has attracted significant attention [2, 7–9].
In the present study, ADC values were assessed using an
ADC histogram to avoid the possible bias arising from the
manual selection of ROIs from the ADC map. Meanwhile,
cerebral blood flow (CBF) using pCASL, and rCBF using
DSC-PWI were also investigated. The accuracy of brain tu-
mour grading by each technique, as well as the combination of
ADC values and contrast-free pCASL sequences, was inves-
tigated in a cohort of patients with astrocytic tumours.
Materials and methods
Subjects
This prospective study was approved by institutional ethics
committee, and written informed consent was obtained from
all the adult patients or from the parents of the paediatric
patients. Between May 2012 and September 2014, 43 consec-
utive patients with suspected astrocytic tumours and preoper-
ative MR imaging examinations including conventional MRI,
DWI, pCASL, and DSC-PWI were included in the study.
There were 25 males and 18 females, and their age ranged
from 6 to 74 years, with a mean age of 43.3 years. All patients
received preoperative assessment of internal carotid arteries
usingMR angiography and there were no significant stenoses.
Laboratory tests showed normal renal function in all patients.
MR imaging protocols
All MR images were obtained on a 3.0 T MR scanner (Dis-
covery 750, GE Healthcare, Milwaukee, WI, USA) with a 32-
channel head coil. Conventional MR scans included pre-
contrast axial T1WI, axial, sagittal, and coronal T2WI, and
post-contrast T1WI. T1WI was performed using T1-FLAIR
(repetition time/echo time/inversion time [TR/TE/TI] =1,
750 ms/24 ms/780 ms, slice thickness=5.0 mm, slice gap=
1.5 mm, field of view=24×18 cm, matrix=320×320, and
NEX=1.0). Axial T2WI was performed using FRFSE (fast
recovery fast spin echo) (TR/TE=4,526 ms/111 ms, slice
thickness=5.0 mm, slice gap=1.5 mm, field of view=24×
24 cm, matrix=192×192, echo train length=32, and NEX=
1.5). Sagittal and coronal T2WI were performed using T2-
FLAIR (TR/TE/TI=8,500 ms/163 ms/2,100 ms, slice thick-
ness=5.0 mm, slice gap=1.5 mm, field of view=20×20 cm,
matrix=288×224, and NEX=1.0).
DWI was performed using fat-suppressed single-shot spin-
echo echo-planar imaging (TR/TE =6,000 ms/65.7 ms, slice
thickness=5.0 mm, slice gap=1.5 mm, field of view=24×
24 cm, matrix=192×192, NEX=2) with b=1,000 s/mm2 ap-
plied in the x, y, and z directions, and b=0 s/mm2 without
motion-probing gradients, followed by automatic generation
of isotropic DWI.
pCASL was performed using a background suppressed 3D
fast spin echo (FSE) technique. The parameters were as fol-
lows: TR=4,653 ms; TE=10.5 ms; post-labelling delay=1,
525 ms; FOV=24×24 cm; matrix=512×512; slice thick-
ness=4.0 mm; slice gap=0 mm; NEX=2, and 36 pairs of
tag and control images were acquired in 4 min 30 s. The
imaging position extended from the vertex to the base of the
skull.
DSC-PWI was then performed with single-shot gradient-
recalled echo-planar imaging (GRE-EPI) sequence (TR/TE=
1,525 ms/minimum, 250 Hz/pixel bandwidth for the
3424 Eur Radiol (2015) 25:3423–3430
acquisition of 20 axial sections, FOV=24×24 cm, 1.0×1.0×
5 mm voxel size, flip angle=60°, matrix=128×128, slice
thickness=5 mm, slice gap=1.5 mm, NEX=1, and number
of slices=20 for 60 phases). Sixty images were obtained for
each slice. Fat saturation was used to optimize the signal-to-
noise ratio and baseline values. After five phases, 0.1 mmol/
kg Gd-DTPA (Bayer Schering Pharma AG, Berlin, Germany)
was injected at a rate of 3 ml/sec, immediately followed by a
20 ml bolus of saline at the same injection rate. The total
imaging time was 1 min 32 s. Preload injection of contrast
media before DSC-PWI acquisition was not applied.
Post-contrast T1WI was finally performed using FSPGR
(fast spoiled gradient recalled echo) (TR/TE/TI=6.2 ms/
2.8 ms/18 ms, slice thickness=4.0 mm, slice gap=0 mm, field
of view=24×24 cm, matrix=288×224) in axial, sagittal, and
coronal planes.
MR data processing
ADC, CBF and rCBF color maps were post-processed using
Functool software (GE Healthcare, Milwaukee, WI, USA) on
a SUN GE AW 4.5 workstation. ADC, CBF, and rCBF mea-
surements were conducted by a neuroradiologist with 5 years’
experience in neuroradiology. Patient-related information was
removed from all images, and the observer was blinded to the
pathological diagnosis. All values were measured again with
an interval of 3 months, and the intraobserver agreement was
evaluated. The average values of initial and second measure-
ments were regarded as the final ADC, normalized CBF
(nCBF), and normalized rCBF (nrCBF) values.
In the present study, an ADC histogram was generated and
the parameters involving the entire lesion were used for ac-
quisition. Volume rendering was used to retrieve the ADC
map. The tumour volume was obtained in each slice of the
axial, coronal, and sagittal planes by identifying the tumour
contour with a colored brush and using the histogram pattern
to obtain the tumour’s ADC histogram. The tumour margins
were defined by using conventional T2WI (FRFSE and FLAI
R) and post-contrast T1WI, and the necrotic/cystic or hemor-
rhagic regions in the tumours defined by conventional T2WI,
pre-contrast and post-contrast T1WI were avoided in ADC
images. By manual placing the metering rod at the lower
10 %, 25 %, and 50 % on ADC histogram curve, the mean
10 %, mean 25 %, mean 50 %, mean, minimum, and maxi-
mum ACD values were determined (Figs. 1, 2).
Maximal perfusion values, including maximal CBF
(pCASL) and maximal rCBF (DSC-PWI) of the tumours,
were measured as follows: on all the continuous pCASL
(Figs. 1e, 2e) and DSC-PWI slices (Figs. 1g, 2g), five to eight
round ROIs (28–32 mm2) were manually and carefully drawn
in the deep color areas within the solid tumour portions on
each slice, and the ROIs with the highest CBF and rCBF
values were selected from the whole tumour. Those CBF
and rCBF values were regarded as the final maximal values.
Since some DSC-PWI and PET studies have verified that cer-
ebellar perfusion is usually stable and unaffected by pathology
[8, 10, 11], the normalization with the cerebellum was used in
the present study, and nCBF on pCASL and nrCBF on DSC-
PWI were defined as the mean value for ROI in a tumour area
Fig. 1 A sixteen-year-old girl with anaplastic astrocytoma (WHO III) in
the right basal ganglion and thalamus. a The tumour showed hyperintense
signal on T2WI. b The tumour showed patchy enhancement on post-
contrast T1WI. c ADC map. d ADC histogram of the tumour. e ROI
selection for the maximal CBF of the tumour on pCASL CBF color
map. f ROI selection for bilateral cerebellum CBF on pCASL CBF
color map. g ROI selection for the maximal rCBF of the tumour on
DSC-PWI rCBF color map. h ROI selection for bilateral cerebellum
rCBF on DSC-PWI rCBF color map
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with maximal perfusion/mean value for ROI in cerebellum.
Cerebellar ROIs (approximately 250 mm2 on each side) were
placed in the central regions of the bilateral cerebellar hemi-
spheres (Figs. 1–2f, h), and the mean value was regarded as
the reference. Cerebellar reference ROIs were not influenced
by cerebellar tumours (one pilocytic astrocytoma) in this study
because of the small tumour size.
Pathological observation
All patients underwent navigation-guided (n=28) or open sur-
gery (n=15) within 7 days after the MR scan. For both surgi-
cal approaches, the tumour portions with maximal perfusion
onMR imaging were used for guidance and should be includ-
ed in the surgical resection. All specimens obtained for path-
ological observation were fixed in formalin and embedded in
p a r a f f i n . Hema t oxy l i n and eo s i n - s t a i n ed and
immunohistochemically prepared specimens were performed
to determine the histological type of the tumour after surgery.
The pathological diagnosis was made by a pathologist with
20 years of experience in neuropathology. According to the
World Health Organization (WHO) criteria [12], tumours of
WHO grade I and II were classified as low-grade astrocytoma
(LGA), whereas tumours of WHO grade III and IV were clas-
sified as high-grade astrocytoma (HGA).
Statistical analysis
Intraobserver agreement was assessed with the intraclass cor-
relation coefficient (ICC), in which ICC<0.40=poor, 0.40–
0.59=fair, 0.60–0.74=good, and>0.74=excellent.
All statistical analyses were performed using the statistical
package SPSS for Windows (Version 16.0, Chicago, IL,
USA). The level of significance was set at p<0.05. ADC
values, nCBF and nrCBF between LGA and HGAwere ana-
lyzed and compared using one-way ANOVA and Student’s
unpaired t-test.
Pearson’s correlation analysis was performed between
nCBF and nrCBF, between ADC values and nCBF, and be-
tween ADC values and nrCBF, respectively.
Receiver operating characteristic (ROC) curves for ADC
values, nCBF, and nrCBF were applied to assess the cutoff
value that best balanced sensitivity and specificity to allow
differentiation between LGA and HGA. Binary logistic re-
gression was performed using mean 10 % ADC + nCBF,
and mean 10 % ADC + nrCBF, respectively. In each patient,
five predicted probabilities produced from mean 10 % ADC,
nCBF, nrCBF, mean 10 % ADC + nCBF, and mean 10 %
ADC + nrCBF were set as the variables, and each predicted
probability was evaluated using ROC curve [13].
Results
Pathological results
Nineteen LGAs (one pilocytic astrocytoma and 18 diffuse
astrocytomas) and 24 HGAs (six anaplastic astrocytomas
and 18 glioblastomas) were proved by pathology.
Fig. 2 A sixty-year-old woman with diffuse astrocytoma (WHO II) in the
right frontal lobe. a The tumour showed hyperintense signal on T2WI. b
The tumour demonstrated no enhancement on post-contrast T1WI. cADC
map. d ADC histogram of the tumour. e ROI selection for the maximal
CBF of the tumour on pCASLCBF color map. fROI selection for bilateral
cerebellum CBF on pCASL CBF color map. g ROI selection for the
maximal rCBF of the tumour on DSC-PWI rCBF color map. h ROI
selection for bilateral cerebellum rCBF on DSC-PWI rCBF color map
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ICC evaluation
The intraobserver reproducibility of mean 10 % ADC mea-
surements on ADC histogram, nCBF measurements on 3D-
pCASL, and nrCBF measurements on DSC-PWI was excel-
lent. ICCs were 0.927 for ADC values, 0.869 for nCBF, and
0.850 for nrCBF, respectively.
ADC histogram parameters, nCBF, and nrCBF
The ADC values of LGAwere significantly higher than those
of HGA using the mean 10 %, mean 25 %, mean, and mini-
mum ADC values, and the difference was most significant by
using the mean 10 % ADC value (p<0.001). The differences
were not significant using the mean 50% and maximumADC
values (Table 1).
The nCBF (1.810±0.979) in the LGA group was signifi-
cantly lower than that (4.505±2.270) in the HGA group
(p<0.001), and the nrCBF (2.070±1.048) in the LGA group
was significantly lower than that (5.922±2.630) in the HGA
group (p<0.001) (Table 2).
Pearson’s correlation analysis showed a significant positive
correlation between nCBF and nrCBF (r=0.751, p<0.001)
(Fig. 3a). The mean 10 % ADC value was chosen, and
Pearson’s correlation analysis showed a negative correlation
between the mean 10 % ADC and nCBF (r=-0.323, p<0.01)
(Fig. 3b) and betweenmean 10%ADC and nrCBF (r=-0.430,
p<0.01) (Fig. 3c).
ROC analysis
The results of the ROC analysis using the mean 10 % ADC
value, nCBF, nrCBF, mean 10 % ADC + nCBF, and mean
10 % ADC + nrCBF for the differentiation between LGA and
HGAwere presented in Table 3 and Fig. 4. The accuracy was
74.4 % for mean 10 % ADC value, 86.1 % for nCBF, and
88.6% for nrCBF, respectively. Combining the cutoff value of
mean 10 % ADC with nCBF or nrCBF could improve the
grading accuracy up to 97.7 % or 95.3 %, respectively.
According to the linear interpolation method, the diagnos-
tic point based on the ROC was calculated as predicted prob-
ability for mean 10 % ADC + nCBF (P1) or predicted prob-
ability for mean 10%ADC+ nrCBF (P2). The best diagnostic
points were 0.354 for P1 and 0.488 for P2, respectively, which
meant if the predicted probability was higher than or equal to
0.354 or 0.488, the tumour could be diagnosed as HGA rather
than LGA, and vice versa. The logistic regression equation
was built and is described as follows:
P1 ¼ 1
1þ e− 15:544−2:657E4X1 þ2:445X2ð Þ
P2 ¼ 1
1þ e− 19:758−3:027E4X1 þ1:371X3ð Þ
(X1: mean 10 % ADC value; X2: nCBF value; X3: nrCBF
value; E4: 104)
Discussion
In this study, we noted that a close correlation was presented
between nCBF (3D-pCASL) and nrCBF (DSC-PWI) in astro-
cytic tumour grading, which was in agreement with the results
of previous studies [14]. Although the overlap in nCBF or
nrCBF at the cutoff values was noticed, most patients in the
LGA group had values below the threshold, while most pa-
tients in the HGA group had values above the threshold. One
grade II astrocytoma, which abutted the cerebral convexity
and falx, showed obvious hyperperfusion on 3D-pCASL with
an increased nCBF value of 4.88. The possible explanation
could be that the tumour was closely related with the adjacent
meningeal vessels. However, its nrCBF value of 1.58 was not
as high as expected. Susceptibility of DSC-PWI may result in
decreased perfusion in such superficial lesions.
A histogram is a plot in which widths represent class inter-
vals and areas are proportional to the corresponding frequen-
cies. The key point was to ensure that the tumour boundary
should be outlined accurately by encompassing the entire tu-
mour, avoiding necrosis, haemorrhage, and peripheral oedema.
Althoughmultiple parameters from the ADC histogram can be
used to grade astrocytic tumours, the statistical results indicat-
ed that in this study the mean 10 % ADC value was most
significant in differentiating LGA fromHGA. The cutoff value
of mean 10 % ADC (0.764×10-3 mm2/s) in this study was
Table 1 ADC histogram values (mean±SD) (×10-3 mm2/s) of LGA
and HGA
LGA (n=19) HGA (n=24) p value
Mean 10 % ADC 0.886±0.118 0.745±0.079 < 0.001
Mean 25 % ADC 1.005±0.195 0.844±0.089 0.003
Mean 50 % ADC 1.167±0.302 1.239±0.108 0.752
Mean ADC 1.418±0.375 1.204±0.188 0.019
Minimum ADC 0.625±0.071 0.548±0.093 0.038
Maximum ADC 3.437±0.578 3.310±0.676 0.519
SD=standard deviation
Table 2 The nCBF and nrCBF (mean±SD) of LGAs and HGAs
LGA (n=19) HGA (n=24) p value
nCBF 1.810±0.979 4.505±2.270 < 0.001
nrCBF 2.070±1.048 5.922±2.630 < 0.001
SD=standard deviation
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lower than those (0.900×10-3 mm2/s and 1.01×10-3 mm2/s)
reported in other studies based on manual ROI measurement
[4, 15]. The discrepancymight be mainly due to the differences
in the sampling methodology. Moreover, disruptions in the
Fig. 3 a Scatterplot of the correlation between the nCBF and nrCBF in LGAs and HGAs. b Scatterplot of the correlation between the mean 10 % ADC
value and nCBF in LGAs and HGAs. c Scatterplot of the correlation between the mean 10 % ADC value and the nrCBF in LGAs and HGAs
Table 3 ROC analysis of the mean 10 % ADC (×10-3 mm2/s), nCBF, nrCBF, mean 10 % ADC+ nCBF, and mean 10 % ADC+ nrCBF values for
astrocytic tumour grading
Cutoff value AUC Sensitivity Specificity Accuracy
Mean 10 % ADC 0.764 0.875 94.7 % 62.5 % 74.4 %
nCBF 2.374 0.919 91.7 % 84.2 % 86.1 %
nrCBF 3.464 0.939 79.2 % 94.7 % 88.6 %
Mean 10 % ADC + nCBF N/A 0.974 N/A N/A 97.7 %
Mean 10 % ADC + nrCBF N/A 0.974 N/A N/A 95.3 %
N/A=not available
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class intervals on histogram were found in some tumours,
which could be compensated by using the mean 10 % ADC
value. Future study is needed to compare the accuracy between
histogram-generated ADC values and manual ROI-defined
ADC values in tumour grading [4, 15, 16].
The present investigation demonstrated that an inverse cor-
relation existed between mean 10 % ADC value and both
nCBF and nrCBF, suggesting that increased cellularity (low
ADC) was correlated with high vascularity (high nCBF or
nrCBF) in astrocytic tumours. ADC value could be used in
astrocytic tumour grading, which has been shown to reflect
the histologically determined cellular density [17, 18]. We
believe that mean 10 % ADC value had intrinsic advantages,
although its overall efficacy was inferior to pCASL and DSC-
PWI in this study. For example, the ADC value could be used
to compensate for the decreased grading accuracy in some
LGAs with high CBF or HGAs with low CBF. One aforemen-
tioned case of grade II astrocytoma with hyperperfusion on
nCBF could be properly graded as LGA by using the mean
10 % ADC value (0.848×10-3 mm2/s), which was higher than
the cutoff value (0.764×10-3 mm2/s)[19]. In this case, a cor-
rect tumour grading could also be achieved by using P2 value
(0.023), which was lower than the diagnostic point (0.488).
In this study, the accuracy for astrocytic tumour grading
was improved by combining the mean 10 % ADC value with
perfusion-base techniques such as 3D-pCASL or DSC-PWI
as compared with individual methods. Our results also indi-
cated that the accuracy of astrocytic tumour grading by com-
bined ADC value and perfusion parameters was higher than
those in previous studies [1, 10, 15, 20]. The authors consid-
ered that the use of predicted probabilities (P1 and P2 values)
was practicable in clinical practice. Moreover, when the pa-
tients were under the conditions of chronic kidney disease,
dialysis, hyperphosphatemia, acidosis, and pro-inflammatory
events, gadolinium-based contrast agents should be used with
caution [21], and the combination of MR techniques, includ-
ing ADC values and contrast-free pCASL, should be the pre-
ferred method of choice for tumour grading.
Limitations of the present study were as follows. 1) The
sample size was not large enough to make a further discussion
on histological subtypes of LGAs and HGAs. 2) Only one
post-labelling delay time (1,525 ms) in pCASL was used,
which may have potential influences on the evaluation of ce-
rebral flow in some cases. 3) Uncorrected maps in pCASL
were used. To decrease the partial volume effects of pCASL
acquisitions, a previous study acquired both uncorrected maps
and maps corrected for partial volume effects, which yielded
similar results, and CBF maps corrected for partial volume
effects were not feasible for clinical use [22]. 4) Different slice
thickness existed between 3D pCASL and 2D DSC-PWI;
therefore, voxel-wise correlation could not be achieved be-
tween them, but anatomical correlation could be determined
in assessing the perfusion values. 5) A major concern about
the calculation errors of nrCBF values with DSC-PWI is the
leakage of contrast agent from the vasculature to the tumour.
Attempts to correct the calculation errors include preload in-
jection of a small amount of contrast agent, use of dual-echo
pulse sequence and baseline subtraction, but none of them are
considered to be the satisfactory method of choice. Therefore,
DSC-PWI without preload of contrast agent are clinically
acceptable.
In conclusion, the mean 10 % ADC value based on ADC
histogram had its intrinsic advantages and could be an objec-
tive method in predicting astrocytic tumour grading. pCASL
could be reliably applied in tumour grading, since it had a
significant positive correlation with DSC-PWI. The combina-
tion of ADC values and pCASL or DSC-PWI could markedly
improve the accuracy for astrocytic tumour grading. Particu-
larly, the combination of ADC values and contrast-free
pCASL sequences could offer a clinically valuable method
of choice in patients with major risk factors and in patients
who need follow-up studies.
Acknowledgements The scientific guarantor of this publication is Lin
Ma. The authors of this manuscript declare relationships with the follow-
ing companies: GE Healthcare. The authors of this manuscript declare no
relationships with any companies, whose products or services may be
related to the subject matter of the article. The authors state that this work
has not received any funding.
Zhi-Ye Chen kindly provided statistical advice for this manuscript.
Institutional ReviewBoard approval was obtained.Written informed con-
sent was obtained from all subjects (patients) in this study. Methodology:
prospective, diagnostic or prognostic study, performed at one institution.
Fig. 4 ROC map of the mean 10 % ADC, nCBF, nrCBF, mean 10 %
ADC+ nCBF, andmean 10%ADC+ nrCBF values for the discrimination
of LGAs vs. HGAs
Eur Radiol (2015) 25:3423–3430 3429
Open Access This article is distributed under the terms of the Creative
Commons Attribution-NonCommercial 4.0 International License (http://
creativecommons.org/licenses/by-nc/4.0/), which permits any noncom-
mercial use, distribution, and reproduction in any medium, provided
you give appropriate credit to the original author(s) and the source, pro-
vide a link to the Creative Commons license, and indicate if changes were
made.
References
1. Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity,
specificity, and predictive values of perfusion MR imaging and
proton MR spectroscopic imaging compared with conventional
MR imaging. AJNR Am J Neuroradiol 24:1989–1998
2. Roy B, Awasthi R, Bindal A et al (2013) Comparative evaluation of
3-dimensional pseudocontinuous arterial spin labeling with dynam-
ic contrast-enhanced perfusion magnetic resonance imaging in
grading of human glioma. J Comput Assist Tomogr 37:321–326
3. Romano A, Rossi Espagnet MC, Calabria LF et al (2012) Clinical
applications of dynamic susceptibility contrast perfusion-weighted
MR imaging in brain tumours. Radiol Med 117:445–460
4. Chen Z, Ma L, Lou X et al (2010) Diagnostic value of minimum
apparent diffusion coefficient values in prediction of neuroepithelial
tumor grading. J Magn Reson Imaging 31:1331–1338
5. Barrett T, Brechbiel M, Bernardo M et al (2007) MRI of tumor
angiogenesis. J Magn Reson Imaging 26:235–249
6. Petcharunpaisan S, Ramalho J, Castillo M (2010) Arterial spin la-
beling in neuroimaging. World J Radiol 2:384–398
7. Nielsen JF, Hernandez-Garcia L (2013) Functional perfusion imag-
ing using pseudocontinuous arterial spin labeling with low-flip-
angle segmented 3D spiral readouts. Magn ResonMed 69:382–390
8. Jarnum H, Steffensen EG, Knutsson L et al (2010) Perfusion MRI
of brain tumours: a comparative study of pseudo-continuous arterial
spin labelling and dynamic susceptibility contrast imaging.
Neuroradiology 52:307–317
9. Wheaton AJ, Miyazaki M (2012) Non-contrast enhanced MR an-
giography: physical principles. J Magn Reson Imaging 36:286–304
10. Thomsen H, Steffensen E, Larsson EM (2012) Perfusion MRI (dy-
namic susceptibility contrast imaging) with different measurement
approaches for the evaluation of blood flow and blood volume in
human gliomas. Acta Radiol 53:95–101
11. Arbab AS, Aoki S, Toyama K et al (2001) Brain perfusion mea-
sured by flow-sensitive alternating inversion recovery (FAIR) and
dynamic susceptibility contrast-enhanced magnetic resonance im-
aging: comparison with nuclear medicine technique. Eur Radiol 11:
635–641
12. Fuller GN, Scheithauer BW (2007) The 2007 Revised World
Health Organization (WHO) Classification of Tumours of the
Central Nervous System: newly codified entities. Brain Pathol 17:
304–307
13. Chen Z, Feng F, Yang Y et al (2012) MR imaging findings of the
corpus callosum region in the differentiation between multiple scle-
rosis and neuromyelitis optica. Eur J Radiol 81:3491–3495
14. Lehmann P, Monet P, de Marco G et al (2010) A comparative study
of perfusion measurement in brain tumours at 3 Tesla MR: arterial
spin labeling versus dynamic susceptibility contrast-enhancedMRI.
Eur Neurol 64:21–26
15. Murakami R, Hirai T, Sugahara T et al (2009) Grading astrocytic
tumors by using apparent diffusion coefficient parameters: superi-
ority of a one- versus two-parameter pilot method. Radiology 251:
838–845
16. Bilgili Y, Unal B (2004) Effect of region of interest on interobserver
variance in apparent diffusion coefficient measures. AJNR Am J
Neuroradiol 25:108–111
17. Gupta RK, Cloughesy TF, Sinha U et al (2000) Relationships be-
tween choline magnetic resonance spectroscopy, apparent diffusion
coefficient and quantitative histopathology in human glioma. J
Neurooncol 50:215–226
18. Rollin N, Guyotat J, Streichenberger N et al (2006) Clinical rele-
vance of diffusion and perfusion magnetic resonance imaging in
assessing intra-axial brain tumors. Neuroradiology 48:150–159
19. Rumboldt Z, Camacho DL, Lake D et al (2006) Apparent diffusion
coefficients for differentiation of cerebellar tumors in children.
AJNR Am J Neuroradiol 27:1362–1369
20. KimMJ, KimHS et al (2008) Diagnostic accuracy and interobserv-
er variability of pulsed arterial spin labeling for glioma grading.
Acta Radiol 49:450–457
21. Zou Z, Ma L, Li H (2009) Incidence of nephrogenic systemic fi-
brosis at Chinese PLA General Hospital. J Magn Reson Imaging
30:1309–1312
22. Binnewijzend MA, Kuijer JP, Benedictus MR et al (2013) Cerebral
blood flow measured with 3D pseudocontinuous arterial spin-
labeling MR imaging in Alzheimer disease and mild cognitive im-
pairment: a marker for disease severity. Radiology 267:221–230
3430 Eur Radiol (2015) 25:3423–3430
